Laverock Therapeutics develops advanced therapies by reprogramming the cell's own gene control systems. The company uses technology that harnesses naturally-occurring microRNAs (miRNAs) to conditionally silence genes in a programmable, tunable, stable, and specific manner.

Laverock Therapeutics

Next generation programmable cell therapies

We are proud to have been selected as a finalist in this year’s Business Weekly newspaper Awards. 

2023 was transformational year for Laverock Therapeutics and saw us take significant steps in advancing our technology which harnesses the cell’s natural gene regulatory mechanisms to develop a new generation of more effective, safer and accessible programmable advanced therapies. We raised the second largest UK life sciences seed round of 2023, £13.5 million and grew our team by more than 50% in the past year.

The awards cover companies from across the whole of the East of England including Stevenage Bioscience Catalyst, and across sectors including #biotech so we know competition will be fierce. We congratulate all the finalists. https://lnkd.in/ejim8hvh

Tony Quested, Editor said, ‘The competition has attracted a record entry in terms of numbers and the quality throughout the shortlist is also arguably the best we have ever seen.’

Winners will be announced during at a dinner at Queens’ College on September 11. 

#innovation #award #finalist #AdvancedTherapies

Are you ready to take the next step in your scientific career? Laverock Therapeutics is looking for passionate and driven individuals to join our innovative team.

If you’re ready to make a difference and be part of something extraordinary, we want to hear from you.

Apply now and embark on an exciting journey with Laverock Therapeutics!
#Careers #JobOpening #ScientificJobs #LaverockTherapeutics #JoinOurTeam

https://lnkd.in/emdgFBkg

Could you be our next star Scientist? Come and join the team :)

As one of the innovative companies in the Stevenage Bioscience Catalyst Incubator, we were delighted to see Labour choose the site to launch its Life Sciences Industry Strategy. 
 
We are driving the development of a new generation of effective, safe and accessible advanced therapies to tackle major diseases based on our novel and uniquely powerful gene-silencing technology.
 
#innovation

Developer of a unique gene silencing platform Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by @UKI2S.  

https://lnkd.in/ezutNAaw

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 23, 2024 9:16 AM	9f4e2400
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	c6a8730e
crunchbase profile	general
li profile	general	Aug 23, 2024 9:16 AM	8cad54f1
translate crunchbase fundingrounds	general
peers	general	Aug 23, 2024 9:16 AM	094bd3ac
news basic	general	Aug 23, 2024 9:16 AM	12c4c9cf
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:LAVEROCKTX

Laverock Therapeutics